Okano Hideyuki, Masuda Hiroshi, Ohkubo Chiyoji
Department of Environmental Health, National Institute of Public Health, Tokyo 108-8638, Japan.
Bioelectromagnetics. 2005 Apr;26(3):161-72. doi: 10.1002/bem.20055.
Previously, we found that whole body exposure to static magnetic fields (SMF) at 10 mT (B(max)) and 25 mT (B(max)) for 2-9 weeks suppressed and delayed blood pressure (BP) elevation in young, stroke resistant, spontaneously hypertensive rats (SHR). In this study, we investigated the interrelated antipressor effects of lower field strengths and nitric oxide (NO) metabolites (NO(x) = NO(2)(-) + NO(3)(-)) in SHR. Seven-week-old male rats were exposed to two different ranges of SMF intensity, 0.3-1.0 mT or 1.5-5.0 mT, for 12 weeks. Three experimental groups of 20 animals each were examined: (1) no exposure with intraperitoneal (ip) saline injection (sham-exposed control); (2) 1 mT SMF exposure with ip saline injection (1 mT); (3) 5 mT SMF exposure with ip saline injection (5 mT). Arterial BP, heart rate (HR), skin blood flow (SBF), plasma NO metabolites (NO(x)), and plasma catecholamine levels were monitored. SMF at 5 mT, but not 1 mT, significantly suppressed and retarded the early stage development of hypertension for several weeks, compared with the age matched, unexposed (sham exposed) control. Exposure to 5 mT resulted in reduced plasma NO(x) concentrations together with lower levels of angiotensin II and aldosterone in SHR. These results suggest that SMF may suppress and delay BP elevation via the NO pathways and hormonal regulatory systems.
此前,我们发现,让年轻的、抗中风的自发性高血压大鼠(SHR)全身暴露于10 mT(B(max))和25 mT(B(max))的静磁场(SMF)中2 - 9周,可抑制并延缓血压(BP)升高。在本研究中,我们调查了较低场强与一氧化氮(NO)代谢产物(NO(x) = NO(2)(-) + NO(3)(-))在SHR中的相关降压作用。将7周龄雄性大鼠暴露于两个不同范围的SMF强度,即0.3 - 1.0 mT或1.5 - 5.0 mT,持续12周。对三个实验组进行检查,每组20只动物:(1)不暴露,腹腔内(ip)注射生理盐水(假暴露对照);(2)暴露于1 mT SMF并ip注射生理盐水(1 mT);(3)暴露于5 mT SMF并ip注射生理盐水(5 mT)。监测动脉血压、心率(HR)、皮肤血流量(SBF)、血浆NO代谢产物(NO(x))和血浆儿茶酚胺水平。与年龄匹配的未暴露(假暴露)对照相比,5 mT的SMF可显著抑制并延缓高血压的早期发展数周,但1 mT的SMF则无此作用。暴露于5 mT会使SHR的血浆NO(x)浓度降低,同时血管紧张素II和醛固酮水平也降低。这些结果表明,SMF可能通过NO途径和激素调节系统抑制并延缓BP升高。